30
/fr/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
April 1, 2024
Public Timelines
FAQ
Menu
Public Timelines
FAQ
Public Timelines
FAQ
For education
For educational institutions
For teachers
For students
Open cabinet
For educational institutions
For teachers
For students
Open cabinet
Créer
Close
Create a timeline
Public timelines
Library
FAQ
Télécharger
Export
Créer une copie
Premium
Intégrer dans le site Web
New timeline
Éditer
mise à jour avec succès 4 oct. 2017
Apixaban clinical trial timeline
0
0
310
Share
Auteurs
Created by
Sai Iyer Ph.D
List of Edits
Attachments
Comments
Périodes
PHASE 3 OL - Apixaban vs. LMWH in clot reduction in CR-VTE
PHASE 1 - Single Dose of Apixaban in Pediatric Subjects at Risk for a Thrombotic Disorder
Phase 2 PK/safety vs. VKA and LMWH in pts w/ congenital or acquired heart disease
Regulatory Post-Marketing Surveillance In Clinical Practice for Venous Thromboembolism (VTE) Treatment and Prevention Of Recurrent VTE
PH 3 - Clot reduction in leukemia pediatrics with central catheters
Apixaban for the Acute Treatment of Venous Thromboembolism in Children
VTE prevention in multiple myeloma
About & Feedback
Un accord
Confidentialité
Bibliothèque
2024
©
Time.Graphics
Support 24/7
Cabinet
Get premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL
Excellent (Trustpilot Reviews)
Based on 115+ reviews
Write your own review on
Trustpilot.com
Comments